Puma Biotech Investor Class Certified In Stock Drop Case
A California federal judge on Friday granted class certification to Puma Biotechnologies Inc. investors in a stock drop suit accusing the company of misrepresenting the effectiveness of a breast cancer treatment...To view the full article, register now.
Already a subscriber? Click here to view full article